ctrl K

Hikma Pharmaceuticals (HKMPY)

PNK: HKMPY · Real-Time Price · USD

52.97

0.00 (0.00%)

At close: Apr 30, 2025, 3:45 PM

Hikma Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	3.13B	2.88B	2.52B	2.55B	2.34B	2.21B	2.07B	1.94B	1.95B
Cost of Revenue	1.71B	1.47B	1.28B	1.25B	1.14B	1.06B	1.02B	969M	964M
Gross Profit	1.42B	1.41B	1.24B	1.3B	1.2B	1.15B	1.05B	967M	986M
Operating Income	612M	367M	507M	582M	579M	493M	371M	-747M	302M
Interest Income	8M	7M	3M	30M	47M	67M	3M	2M	12M
Pretax Income	455M	281M	233M	544M	558M	491M	293M	-738M	210M
Net Income	359M	190M	188M	421M	431M	486M	282M	-843M	155M
Selling & General & Admin	568M	638M	509M	488M	464M	494M	470M	426M	392M
Research & Development	141M	149M	144M	143M	137M	150M	147M	115M	150M
Other Expenses	94M	253M	103M	111M	86M	11M	55M	48M	81M
Operating Expenses	803M	1.04B	756M	742M	687M	655M	690M	635M	611M
Interest Expense	88M	87M	77M	69M	69M	67M	80M	60M	104M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	494M	224M	188M	184M
Cost & Expenses	2.52B	2.51B	2.04B	1.99B	1.83B	1.71B	1.71B	1.6B	1.57B
Income Tax Expense	93M	89M	42M	124M	128M	4M	8M	101M	52M
Shares Outstanding (Basic)	110.67M	55.22M	56M	57.75M	59M	60.5M	60.25M	60M	58.25M
Shares Outstanding (Diluted)	111.75M	55.59M	56.25M	58.25M	59.5M	60.75M	60.5M	60.25M	58.5M
EPS (Basic)	3.24	3.44	3.36	7.30	7.30	8.04	4.68	-14.04	2.66
EPS (Diluted)	3.22	3.42	3.34	7.22	7.24	8.00	4.66	-14	2.64
EBITDA	739M	559M	493M	766M	747M	660M	456M	-543M	383M
EBIT	530M	368M	303M	599M	612M	543M	347M	-679M	271M
Depreciation & Amortization	197M	191M	190M	167M	135M	117M	109M	136M	112M